October 2013 FDA Recall Cefepime Hydrochloride And Dextrose by B. Braun Medical Inc
D-1054-2014 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by B. Braun Medical Inc on October 15, 2013 for the product Cefepime Hydrochloride And Dextrose. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1054-2014

Reason for Recall
Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
Initiated
10-15-2013
Reported
02-12-2014
Quantity
18,936 Containers

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
B. Braun Medical Inc
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose, Sterile/Non pyrogenic, Rx Only, B Braun Medical Inc., NDC 0264-3193-11

Batch or Lot Expiration Information

Lot# Lot H3A744, Exp 01/15